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Introduction {#sec1}
============

Human pluripotent stem cells (hPSCs) have emerged as an advantageous *in vitro* model for studying neural development and neurodegeneration, as these cells can be differentiated into any cell type of the body, including those of the nervous system ([@bib6], [@bib19], [@bib26], [@bib31], [@bib48], [@bib58]). Moreover, when derived from patient-specific sources, hPSCs can serve as powerful tools for disease modeling as well as large-scale pharmacological screens ([@bib7], [@bib14], [@bib18]). However, for hPSCs to effectively serve in these applications, they must closely mirror the phenotypic and functional features of the affected cell type. Retinal ganglion cells (RGCs) form the essential connection between the eye and the brain, allowing for visual transduction and the ability to see. This important connection becomes severed in numerous blinding disorders termed optic neuropathies, which cause progressive degeneration and eventual death of RGCs in the retina ([@bib2], [@bib57]).

Previous studies have demonstrated the ability to successfully differentiate RGCs from hPSCs in an efficient and reproducible manner ([@bib10], [@bib13], [@bib23], [@bib25], [@bib35], [@bib40], [@bib45], [@bib49], [@bib50]). RGCs derived using such methods have recapitulated the developmental timing of the retina, as well as displaying various molecular and morphological characteristics similar to the *in vivo* cell type. As the projection neuron of the retina, RGCs extend long axons through the optic nerve to communicate visual information to the brain. hPSC-derived RGCs have demonstrated some capacity to exhibit predicted electrophysiological characteristics, including the ability to fire action potentials (APs), conduct ionic currents, and respond to glutamate ([@bib13], [@bib35], [@bib40], [@bib45], [@bib49], [@bib50]). However, these studies have often demonstrated somewhat limited functional properties of hPSC-derived RGCs and have failed to take into consideration the milieu of factors known to influence RGC development and maturation. Among the more influential of these factors are contributions from astrocytes, which are known to closely associate with RGCs in the nerve fiber layer and optic nerve ([@bib4], [@bib54], [@bib59]).

As such, the current study focused on characterizing the functional maturation of hPSC (both embryonic stem and induced pluripotent stem)-derived RGCs based upon morphological complexity and electrophysiological properties, over time as well as in response to signaling from astrocytes. Initially, hPSC-derived RGCs demonstrated increased neurite complexity as a function of time, including enlargement of the cell somas and elongation of neurites. In addition, these hPSC-derived RGCs displayed increasing ionic currents, AP excitability, and the expression of synaptic proteins. To study the influence of astrocytes upon hPSC-derived RGC maturation, cells were either plated in co-culture with hPSC-derived astrocytes or supplemented with astrocyte conditioned medium (ACM) to determine substrate-bound or secreted effects of astrocytes on RGCs, respectively. RGCs co-cultured with astrocytes demonstrated expedited and enhanced morphological and functional characteristics compared with RGCs cultured alone. The results of this study clearly demonstrate the functional and morphological maturation of RGCs *in vitro* as well as exploring how astrocytes modulate and expedite this maturation. These results will also lead to the development of more realistic hPSC-derived disease models, with important implications for pharmacological screenings and cell replacement strategies in future studies.

Results {#sec2}
=======

Increased RGC Neurite Complexity Over Time {#sec2.1}
------------------------------------------

RGCs exhibit complex morphological features within the retina, with long axons extending out of the eye through the optic nerve, while a complex and extensive network of dendrites reaches into the inner plexiform layer ([@bib9], [@bib28], [@bib43]). Given this morphological complexity, an hPSC-derived RGC population should also exhibit intricate features to serve as an effective *in vitro* model. However, the study of hPSC-derived RGC morphological features has been somewhat limited in previous studies, as RGCs are often differentiated and examined in a mixed population of other cell types ([@bib22], [@bib30], [@bib47]). In addition, the definitive identification of RGCs within such cultures has been complicated by the lack of unique, reliable markers that allow for the visualization of entire RGCs, including their extensive neurites. Thus, to overcome these issues, a CRISPR/Cas9-engineered cell line with a tdTomato reporter and mouse Thy1.2 selectable marker was used to identify and enrich for hPSC-derived RGCs ([@bib44]).

In accordance with previous studies, hPSC-derived RGCs could be readily observed within the first 40 days of differentiation ([@bib35]), at which point RGCs were enriched and plated to allow for maturation and examination. Over the next 10 days, hPSC-derived RGCs displayed features of increasing neurite complexity, including robust and complex neurite outgrowth ([Figure 1](#fig1){ref-type="fig"}). Purified RGCs demonstrated a dramatic and significant increase in soma size, more than doubling within the first 10 days of growth ([Figure 1](#fig1){ref-type="fig"}J). In addition, RGC neurites grew significantly in length over time, with neurites extending upward of 150 μm within 10 days of plating ([Figures 1](#fig1){ref-type="fig"}F--1I and 1K). The complexity of RGC neurites was examined and they showed increasingly complex morphologies, with the neurite branch order more than doubling within this time course ([Figure 1](#fig1){ref-type="fig"}L). RGC neurites also displayed a 13-fold increase in the number of branchpoints within the first 10 days of growth ([Figure 1](#fig1){ref-type="fig"}M). As such, hPSC-derived RGCs were capable of exhibiting increased morphological complexity over time, including the enlargement of the cell soma and elongation of complex neurites.Figure 1Temporal Acquisition of Complex Neuronal Morphologies by hPSC-Derived RGCs(A) Representative timeline for the experimental differentiation and analysis of hPSC-derived RGCs.(B--I) Immunocytochemistry (ICC) and representative tracings of hPSC-derived RGCs at 1 (B and F), 4 (C and G), 7 (D and H), and 10 days (E and I) post-purification displayed enhanced morphological maturation over time. RGC tracings in (F--I) represent neurites observed at 20× magnification, which allowed for the ability to image the entire cell, but due to the small diameter of the neurites, this level of magnification limited their ability to be readily observed in microscopy images.(J) The area of RGC somas significantly increased over time.(K) The average neurite length of hPSC-derived RGCs significantly increased from 1 to 10 days.(L and M) Last, neurite tracings demonstrated a significant increase in (L) neurite order complexity and (M) number of branches within 10 days of purification.Scale bars, 30 μm. Error bars represent SEM (n = 5 independent replicates for each bar using H7, tiPS5, and miPS2 cell lines) and significance was determined using a 95% confidence interval; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.

Functional Maturation of hPSC-Derived RGCs Over Time {#sec2.2}
----------------------------------------------------

Within the retina, RGCs are the most excitable cells, with the nearly exclusive ability to fire APs necessary for the propagation of visual signals to the brain ([@bib9], [@bib12], [@bib15], [@bib29], [@bib43], [@bib52], [@bib55]). As such, efforts were undertaken to examine the electrophysiological features of hPSC-derived RGCs, as well as how these characteristics change over time ([Figure 2](#fig2){ref-type="fig"}). Voltage-clamp recordings from hPSC-derived RGCs exhibited an increase in peak sodium conductance as neurons matured from 1 to 4 weeks ([Figure 2](#fig2){ref-type="fig"}A). The current-voltage relationship (I-V curve; [Figure 2](#fig2){ref-type="fig"}B) displayed increased sodium currents with the average peak current increasing over time. The voltage dependence of activation for normalized peak sodium conductance showed a significant hyperpolarized shift as the RGCs matured from week 1 to week 2 and further ([Figure 2](#fig2){ref-type="fig"}C), signifying functional maturation of hPSC-derived RGCs that is consistent with the developmental shift observed in rat and mouse RGCs ([@bib41], [@bib42]). Current density plots also displayed an increase in sodium currents from 1 to 4 weeks of RGC maturation, indicating an increase in the expression of voltage-gated sodium channels ([Figure 2](#fig2){ref-type="fig"}D).Figure 2Temporal Development of Functional Maturation of hPSC-Derived RGCs(A) Patch-clamp recordings revealed an increase in inward ionic currents within 4 weeks of purification.(B) From 1 to 4 weeks, I-V curves displayed increased inward current as RGCs matured.(C) Voltage dependence of activation indicated a significant shift in the hyperpolarized direction over time.(D) A current density plot demonstrated a significant increase in sodium currents over 4 weeks.(E) A table representing the increases in peak conductance, midpoints of activation, and current density values at each time point.Error bars represent SEM (n \> 4 independent replicates for each bar using H7, tiPS5, and miPS2 cell lines) and significant differences are indicated as ^∗^p \< 0.05, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.

Subsequently, the ability of hPSC-derived RGCs to fire spontaneous APs was examined, with no spontaneous activity detected after 1 week, but with spontaneous APs elicited as early as 2 weeks ([Figure 3](#fig3){ref-type="fig"}A). By 4 weeks, repetitive AP firing patterns emerged, along with occasional AP bursts. The percentage of hPSC-derived RGCs capable of spontaneous AP firing was found to continually increase from 1 to 4 weeks ([Figure 3](#fig3){ref-type="fig"}B). Furthermore, the average number of spontaneous APs fired increased significantly as hPSC-derived RGCs matured ([Figure 3](#fig3){ref-type="fig"}C).Figure 3Increased Excitability of hPSC-Derived RGCs Occurs in a Temporally Dependent Manner(A) Patch-clamp recordings demonstrated the increased ability of hPSC-derived RGCs to fire spontaneous APs from 1 to 4 weeks post-purification.(B) The percentage of spontaneous APs that increased between 1 (n = 12), 2 (n = 22), 3 (n = 16), and 4 (n = 17) weeks.(C) Spiking behavior of hPSC-derived RGCs from 1 to 4 weeks significantly increased.Error bars represent SEM (n \> 12 independent replicates for each bar using H7, tiPS5, and miPS2 cell lines) and significant differences are indicated as ^∗^p \< 0.05.

To determine if hPSC-derived RGCs were capable of forming presumptive synaptic contacts, the expression of various synaptic proteins was analyzed from 1 to 3 weeks following purification ([Figure 4](#fig4){ref-type="fig"}). hPSC-derived RGCs demonstrated a significant increase in the number of SV2-positive puncta along their neurites from 1 to 3 weeks ([Figures 4](#fig4){ref-type="fig"}A--4D). In addition, western blot analyses revealed an increased expression of synaptic proteins over time, including Synapsin-1, vGlut2, Neurexin-1, and SNAP25 ([Figures 4](#fig4){ref-type="fig"}E and 4F). Taken together, these data reveal that hPSC-derived RGCs exhibited electrophysiological properties and formed presumptive synaptic contacts as predicted by *in vivo* studies, with these features increasing over time.Figure 4Formation of Presumptive Synaptic Contacts by hPSC-Derived RGCs(A--C) ICC demonstrated the increased presence of SV2 puncta within hPSC-derived RGC neurites at (A) 1, (B) 2, and (C) 3 weeks post-purification.(D) The number of SV2 puncta per neurite length significantly increased over time.(E and F) Western blot analyses displayed expression of a number of synaptic proteins (E) with densitometry measurements exhibiting increased expression over time (F).Scale bars, 20 μm. Error bars represent SEM (n = 3 independent replicates for each bar using H7, tiPS5, and miPS2 cell lines) and significant differences were determined at a 95% confidence interval; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001.

Astrocytes Modulate the Morphological Complexity of hPSC-Derived RGCs {#sec2.3}
---------------------------------------------------------------------

Within the retina, astrocytes are closely associated with RGCs within the nerve fiber layer and optic nerve, where they are known to support RGCs through the release of growth factors and reuptake of neurotransmitter and by maintaining ionic balances, among other roles ([@bib1], [@bib3], [@bib33], [@bib36], [@bib54], [@bib56]). In addition, astrocytes have been shown to modulate the maturation of a variety of neuronal cell types and influence their synaptic development *in vitro* ([@bib20], [@bib32]). However, similar experiments have not tested their ability to influence RGC development and maturation. As such, co-cultures with hPSC-derived astrocytes were developed as a strategy to enhance the maturation of hPSC-derived RGCs.

hPSCs were differentiated into an astrocytic lineage ([@bib21]), yielding highly enriched populations of GFAP-positive astrocytes after 9 months of growth ([Figure S1](#mmc1){ref-type="supplementary-material"}). In addition, these astrocyte populations also expressed a multitude of other glial cell markers, including Vimentin, S100β, SOX2, and Nestin ([Figures S1](#mmc1){ref-type="supplementary-material"}C--S1E). The ability of these hPSC-derived astrocytes to support RGCs was also suggested by the expression of Excitatory Amino Acid Transporter 1 (EAAT1), important for the reuptake of excess glutamate at the synapse ([Figure S1](#mmc1){ref-type="supplementary-material"}F). To establish a co-culture system with which to directly study the interactions between astrocytes and RGCs, hPSC-derived RGCs were purified and plated in association with hPSC-derived astrocytes and grown in co-culture for 10 days to observe changes in RGC morphology and neurite outgrowth ([Figure S1](#mmc1){ref-type="supplementary-material"}G). In addition, to separate the effects of astrocytes as either substrate-bound or due to soluble factors secreted into the medium, hPSC-derived RGCs were separately supplemented with ACM.

After 10 days of plating, purified RGCs co-cultured with astrocytes displayed significant and robust neurite outgrowth and complexity compared with RGCs grown alone or supplemented with ACM ([Figures 5](#fig5){ref-type="fig"}A--5F). Astrocyte co-cultures led to significant increases in RGC soma size as well as the average length of the longest neurite, while ACM showed no significant effects ([Figures 5](#fig5){ref-type="fig"}G and 5H). Moreover, RGCs co-cultured with astrocytes displayed significantly more complex neurite outgrowth as indicated by the number of primary, secondary, tertiary, and quaternary neurites and number of branchpoints ([Figures 5](#fig5){ref-type="fig"}I and 5J). As supplementing RGCs with ACM led to no significant changes in morphological analyses, subsequent experiments examined the effects of astrocytes solely through direct contact in co-cultures.Figure 5Astrocytes Expedite and Enhance the Morphological Maturation of hPSC-Derived RGCs(A--F) At 10 days post-purification, ICC and representative neurite tracings of hPSC-derived RGCs displayed enhanced morphological maturation for (C and F) RGCs grown with astrocytes compared with (A and D) RGCs grown alone or (B and E) RGCs supplemented with ACM.(G and H) Significant increases were observed in (G) soma size area and (H) the length of the longest neurite for hPSC-derived RGCs grown with astrocytes.(I and J) Neurite tracings displayed a significant increase in (I) neurite order complexity and (J) number of branches for hPSC-derived RGCs on astrocytes compared with other conditions.Scale bars, 50 μm. Error bars represent SEM (n = 5 independent replicates for each bar using H7, H9, tiPS5, and miPS2 cell lines) and significant differences were determined at a 95% confidence interval; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.

Astrocytes Accelerate the Functional Maturation of hPSC-Derived RGCs {#sec2.4}
--------------------------------------------------------------------

Next, the effects of astrocyte co-cultures on the functional maturation of hPSC-derived RGCs were characterized. Electrophysiological analyses of the evoked APs were conducted on both the RGCs grown alone and those co-cultured with astrocytes at 3 weeks post-purification ([Figures 6](#fig6){ref-type="fig"}A--6D). Quantitatively, RGCs co-cultured with astrocytes demonstrated an increased number of AP firings ([Figure 6](#fig6){ref-type="fig"}E), in response to a steady current injection as well as in response to a ramp depolarization event. In addition, the presence of astrocytes in co-culture with hPSC-derived RGCs increased the AP amplitude ([Figure 6](#fig6){ref-type="fig"}F) and decreased the AP duration ([Figure 6](#fig6){ref-type="fig"}G) compared with RGCs cultured alone. Furthermore, RGCs co-cultured with astrocytes showed a more hyperpolarized AP threshold ([Figure 6](#fig6){ref-type="fig"}H).Figure 6hPSC-Derived Astrocytes Modulate the Functional Maturation of hPSC-Derived RGCs(A and B) Patch-clamp recordings demonstrated the heightened excitability of (B) hPSC-derived RGCs grown on astrocytes compared with (A) hPSC-derived RGCs grown alone.(C and D) A ramp depolarization indicated the ability of (D) hPSC-derived RGCs grown with astrocytes to fire more and repetitive APs compared with (C) RGCs alone.(E--H) hPSC-derived RGCs grown with astrocytes exhibited (E) a higher number of APs fired, (F) increased amplitude, (G) decreased duration, and (H) a more hyperpolarized AP threshold.Error bars represent SEM (n = 8 independent replicates for each bar using H7, H9, tiPS5, and miPS2 cell lines) and significance was determined at a 95% confidence interval; ^∗∗^p \< 0.01, ^∗∗∗∗^p \< 0.0001.

In addition, the ability of astrocytes to enhance the formation of presumptive synaptic contacts was assessed by comparing RGCs grown alone with RGCs co-cultured with astrocytes. RGCs grown with astrocytes displayed a significantly higher number of SV2-positive presumptive synaptic puncta at 10 days post-purification ([Figures 7](#fig7){ref-type="fig"}A--7C), similar to that observed for RGCs plated alone at 3 weeks post-purification ([Figures 4](#fig4){ref-type="fig"}A--4D). Analyses of spontaneous synaptic currents revealed that RGCs co-cultured with astrocytes also exhibited more frequent spontaneous inward ionic currents ([Figure 7](#fig7){ref-type="fig"}D). Furthermore, western blot analyses revealed that RGCs grown in co-culture with astrocytes demonstrated significantly increased expression of a variety of synaptic proteins ([Figures 7](#fig7){ref-type="fig"}E and 7F). Additional western blot analysis confirmed that increased synaptic protein expression in co-cultures was a result of increased RGC maturation and not derived from astrocyte populations ([Figure S2](#mmc1){ref-type="supplementary-material"}).Figure 7Astrocytes Regulate the Synaptic Maturation of hPSC-Derived RGCs(A and B) At 10 days post-purification, ICC demonstrated the increased presence of SV2 puncta within (B) hPSC-derived RGC neurites grown in the presence of astrocytes compared with (A) those grown alone.(C) The number of SV2 puncta significantly increased in hPSC-derived RGCs grown with astrocytes.(D) Patch-clamp recordings demonstrated an increase in the number and frequency of spontaneous post-synaptic currents for RGCs grown with astrocytes.(E and F) Western blot analyses displayed expression of a number of synaptic proteins when hPSC-derived RGCs were grown with astrocytes (E) with densitometry measurements exhibiting increased expression compared to RGCs grown alone (F).Scale bars, 20 μm. Error bars represent SEM (n = 3 independent replicates for each bar using H7, H9, tiPS5, and miPS2 cell lines) and significance was determined at a 95% confidence interval; ^∗∗∗∗^p \< 0.0001.

Discussion {#sec3}
==========

The utilization of hPSCs to study RGCs has been more recently studied with an important emphasis on how these cells can serve as a translational model for the development of RGCs as well as diseases resulting in degeneration and eventual death of these cells ([@bib6], [@bib11], [@bib19]). However, to date, studies of hPSC-derived RGCs have often shown limited functional capabilities and have overlooked the interactions of many other cell types closely associated with RGCs in the retina that can play a vital role in the development and maturation of these cells ([@bib4], [@bib54]). As RGCs form the essential connection between the eye and the brain, these cells demonstrate a number of morphological and functional characteristics unique to RGCs within the retina, including the extension of long and complex neurites and the ability to fire APs ([@bib15], [@bib16], [@bib43], [@bib55]). The generation of hPSC-derived RGCs, which recapitulate these distinctive characteristics, would allow for a more representative model of these cells, with important implications for how these cells can serve as a tool for disease modeling, drug screenings, and future cell replacement therapies. The results of this study demonstrate the derivation of RGCs that exhibit characteristics closely resembling their *in vivo* counterparts, allowing for a greater understanding of how these cells develop and may be affected in disease states. Furthermore, the ability to extensively study the morphological and functional maturation of hPSC-derived RGCs over time demonstrates their ability to acquire advancing features of RGC maturation, with astrocytes significantly expediting and enhancing this maturation.

RGCs are the main cell type affected in numerous blinding disorders that result in the degeneration and death of these cells, leading to loss of vision and eventual blindness ([@bib2], [@bib39], [@bib57]). Therefore, the use of hPSC-derived RGCs allows for the establishment of translational models of these diseases to understand mechanisms causing the death of RGCs, as well as for the development of treatments and therapeutics targeting these disease phenotypes, including large-scale pharmaceutical screenings and potential cell replacement strategies. However, for hPSC-derived RGCs to serve as a reliable disease model, they must closely mimic the phenotypic and functional characteristics of the affected cell type, as disease states often manifest in fully differentiated and functionally mature cells. In the current study, hPSC-derived RGCs exhibited increased morphological complexity and functional maturation over time, including increasing inward ionic currents and the more frequent firing of spontaneous APs, with these features becoming significantly enhanced in the presence of astrocytes. The demonstration of these advancing features of RGC maturation thus allows for the ability to use these cells as a more faithful model for studying diseases affecting the health of RGCs, as well as aiding in the development of therapeutic strategies to target disease mechanisms.

A number of previous studies have demonstrated the ability to derive RGCs from hPSCs, with several of these studies establishing that these RGCs may possess a range of functional properties, including ionic currents, firing of APs, and response to glutamate ([@bib13], [@bib35], [@bib40], [@bib45], [@bib49], [@bib50]). However, these results often indicated a degree of immaturity of these cells, and seldom examined their functional properties beyond a single time point post-purification. Results of the current study showed hPSC-derived RGCs over multiple time points, demonstrating progressive features of their development and growth as they differentiated through various stages of morphological and functional maturity. By 3 weeks, hPSC-derived RGCs were capable of conducting substantial inward ionic currents with a hyperpolarized voltage dependence of activation, firing trains of spontaneous APs, and expressing a variety of synaptic proteins, all characteristics consistent with a functionally mature RGC. The study of hPSC-derived RGCs in such a manner allows for their use as a more appropriate developmental model.

RGCs are the projection neuron of the retina forming the vital connection between the eye and the brain, doing so by extending long and intricate axons through the optic nerve as well as forming complex connections with retinal interneurons within the inner plexiform layers ([@bib28]). The analysis of various morphological properties within 10 days demonstrated a significant increase in the length and complexity of hPSC-derived RGC neurites over time. Similarly, hPSC-derived RGC somas were shown to significantly increase in area over time, comparable with many RGCs found *in vivo* ([@bib24]). Taken together, these results indicated the ability of hPSC-derived RGCs to acquire advancing features of morphological maturation and, as such, establish hPSC-derived RGCs as a more reliable model of RGC development.

RGCs form synaptic contacts both in the retina and in the brain, with pre-synaptic contacts formed with bipolar and amacrine cells in the inner plexiform layer, and post-synaptic contacts formed with targets including the lateral geniculate nucleus and the superior colliculus ([@bib17], [@bib27]). The presence of synaptic features within hPSC-derived RGCs would thus serve as an additional measure of their maturation and, likewise, their effectiveness as an *in vitro* model. A number of synaptic proteins were found to be expressed by hPSC-derived RGCs over time, indicating the formation of presumptive synaptic contacts. The expression of these proteins was found to increase over time, indicating the acquisition of advancing features of maturation. The prospective ability of these hPSC-derived RGCs not only contributes to their effectiveness as an appropriate *in vitro* model, but may also enable their use for cellular replacement if they are capable of incorporating into a neural network.

While hPSC-derived RGCs exhibited numerous features of maturation, many other cell types are known to play a role in this process *in vivo*. Astrocytes are found in close association with RGCs in the nerve fiber layer of the retina as well as within the optic nerve ([@bib54]). These cells provide support to RGCs in a number of ways, including the regulation ionic concentrations, the reuptake of excess neurotransmitters, and the release of various growth factors ([@bib5], [@bib8], [@bib36], [@bib37], [@bib53]). Therefore, the interaction of these two cell types could enhance the maturation of hPSC-derived RGCs when grown in a co-culture. In the current study, the ability of astrocytes to modulate RGC maturation was examined, with effects possibly due to the release of soluble factors or through direct contact between astrocytes and RGCs. hPSC-derived RGCs grown in direct contact with astrocytes displayed expedited and significantly enhanced morphological and functional maturation compared with RGCs grown alone or in the presence of astrocyte-derived soluble factors tested with ACM, including the extension of longer and more complex neurites as well as the ability to fire APs. As soluble factors tested by ACM did not demonstrate any significant differences compared with control experiments, the effects observed via direct contact with astrocytes could potentially be explained by multiple factors. The development of gap junctions between astrocytes and RGCs could allow for communication between these cell types, although preliminary data indicated a lack of expression of Connexin 43 in these cultures (data not shown), likely due to a somewhat immature stage of differentiation. Alternatively, these maturation-enhancing effects could be due to the activation of signaling pathways triggered through substrate-bound ligands found on the astrocytic cell membrane. Regardless, these results established the importance of direct contact between hPSC-derived RGCs and hPSC-derived astrocytes, which more accurately represents an environment similar to that of the retina and optic nerve.

One the most profound effects of astrocytes upon hPSC-derived RGCs was the enhancement of their electrophysiological properties. When grown with astrocytes, these cells had a higher level of activity, including increased firing of APs and presumptive synaptic currents. In addition, these characteristics were often easier to elicit in the presence of astrocytes as indicated by the injection of smaller amounts of current, indicating a heightened excitability of hPSC-derived RGCs. Taken together, these results indicated that co-culturing astrocytes with hPSC-derived RGCs created an expedited and enhanced degree of maturation compared with RGCs cultured alone. Moreover, RGCs co-cultured with astrocytes generated a cell type more closely resembling *in vivo* RGCs with the ability to extend significantly longer and more intricate neurites, fire repetitive APs, and form presumptive synaptic contacts. In future studies, numerous variables will need to be considered to establish the full functionality of hPSC-derived RGCs, as many factors influence the growth and maturation of RGCs *in vivo*, including other glial cells, the blood-brain barrier, as well as the establishment of both pre- and post-synaptic contacts. As such, while the current study clearly demonstrates the ability of astrocytes to enhance maturation of hPSC-derived RGCs, additional efforts will be needed in the future to elucidate cellular and molecular contributors to RGC maturation approaching that of endogenous RGCs. The ability to more faithfully emulate the RGC environment within the retina is also critical for the establishment of cellular replacement strategies, as transplanted RGCs would encounter a variety of factors influencing their integration and growth *in vivo* that would not typically be recapitulated in an *in vitro* setting. Thus, the current studies represent a model that more closely mimics the *in vivo* environment for RGCs, facilitating future studies for cellular replacement.

Overall, the results of the current study indicate the important contributions of astrocytes to RGC development and maturation. In future studies, the role of astrocytes should be considered in the establishment of developmental and disease models utilizing RGCs. The interaction of astrocytes with RGCs would allow for the development of a more mature cell type that can be used to properly identify and further understand disease deficits affecting RGCs. Moreover, given the important role of astrocytes in RGC maturation and function, future studies should also focus on the contributions of astrocytes to disease states and if diseased astrocytes are playing a role in the degeneration of RGCs. Furthermore, given their importance in the maturation and homeostasis of RGCs, astrocytes may provide an alternative target for therapeutics for optic neuropathies, and serve as a target for cell replacement strategies in future studies to enhance the survival and function of endogenous RGCs.

Experimental Procedures {#sec4}
=======================

Maintenance of hPSCs {#sec4.1}
--------------------

hPSCs were grown as previously described ([@bib34]). Multiple hPSC lines were used throughout this study, including H7 ([@bib51]), H9 ([@bib51]), TiPS5 ([@bib38]), and miPS2 ([@bib46]). In short, hPSCs were maintained in the undifferentiated state using human embryonic stem cell-qualified Matrigel (Corning) on six-well plates with mTeSR1 medium (STEMCELL Technologies) at 37°C and 5% CO~2~. Passaging of hPSCs was accomplished by enzymatically lifting colonies using dispase (2 mg/mL) for approximately 15 min. Colonies were then mechanically disrupted to yield small aggregates of cells and split at a 1:6 ratio.

Differentiation of hPSCs into RGCs {#sec4.2}
----------------------------------

hPSCs were differentiated to a retinal fate using previously described protocols with minor modifications ([@bib34]). After 30 days of differentiation, early retinal organoids could be morphologically identified and isolated apart from other forebrain neurospheres. At day 45, retinal organoids were dissociated using Accutase for 20 min at 37°C. Following dissociation, single cells were immunopurified for RGCs with the Thy1.2 surface receptor using the MACS magnetic cell separation kit (Miltenyi Biotec). Briefly, dissociated cells were incubated with CD90.2 microbeads for 15 min at 4°C in the dark at a ratio of 10 μL of beads:90 μL of MACS rinsing buffer per 10 million cells ([@bib44]). Purified RGCs were then plated on poly-D-ornithine and laminin-coated coverslips at a density of 10,000 cells/coverslip and maintained in BrainPhys neuronal medium (STEMCELL Technologies) supplemented with 20 ng/mL CNTF. Coverslips were then fixed at indicated time points post-plating to analyze RGC maturation, or utilized for subsequent patch-clamp recordings.

Astrocyte Differentiation from hPSCs {#sec4.3}
------------------------------------

hPSCs were differentiated to astrocytes using previously described protocols ([@bib21]). Within 40 days of differentiation, early neurospheres were supplemented with 20 ng/mL EFH (FGF2 and EGF) to induce proliferation to a gliogenic phase. Neurospheres were chopped and expanded using a mechanical tissue chopper to a size of 200 μm every 2 weeks for up to 12 months. Between 9 and 12 months, neurospheres became enriched for astrocytes and were then dissociated using Accutase for 20 min at 37°C. Single cells were plated at a density of 20,000 astrocytes per 12 mm coverslip and supplemented with BrainPhys neuronal medium with the addition of 20 ng/mL CNTF to yield GFAP-positive astrocytes within 3 weeks of plating. Subsequently, co-cultures of RGCs and astrocytes were established with 10,000 purified RGCs plated with adhered astrocytes to create a substrate-bound co-culture. In addition, ACM was collected from plated astrocytes, filtered to remove cellular components, and added every other day to RGC cultures at a dilution of 1:1 together with fresh BrainPhys as previously described ([@bib37]). Co-culture experiments were fixed at indicated time points post-plating and analyzed for RGC maturation, or utilized for patch-clamp analysis.

Immunocytochemistry {#sec4.4}
-------------------

Samples were fixed with 4% paraformaldehyde for 30 min and then washed three times with phosphate-buffered saline (PBS). Cells were then permeabilized in 0.2% Triton X-100 for 10 min at room temperature, followed by blocking in 10% donkey serum for 1 hr at room temperature. Primary antibodies ([Table S1](#mmc1){ref-type="supplementary-material"}) were diluted in 5% donkey serum and 0.1% Triton X-100 solution and applied to samples overnight at 4°C. The following day, cells were washed three times with PBS and blocked with 10% donkey serum for 10 min at room temperature. Secondary antibodies were diluted in 5% donkey serum and 0.1% Triton X-100 solution and added for 1 hr at room temperature. The cells were then washed three times with PBS and mounted onto slides for microscopy. Immunofluorescence images were obtained using a Leica DM5500 fluorescence microscope.

Quantification and Statistical Analyses {#sec4.5}
---------------------------------------

Samples were analyzed for RGC maturation based on soma size, neurite length, and complexity. Numerous biological replicates (n = 5) were obtained at each time point. Immunofluorescence images were taken and analyzed for the expression of tdTomato to identify RGCs. The RGC soma size area, neurite length, and branch order were quantified and recorded using ImageJ. Statistical analyses were performed using one-way ANOVA followed by Tukey\'s post hoc. Statistical differences were determined based on a p value of less than 0.05. In addition, the abundance of SV2 puncta was quantified using ImageJ, with the total neurite length associated with SV2 immunoreactivity quantified using the ImageJ plugin NeuronJ. Statistical analyses were performed using one-way ANOVA followed by Tukey\'s post hoc for SV2 expression in RGCs alone over time and Student\'s t test for comparing SV2 expression in RGCs to that in RGCs grown on astrocytes. Statistical differences were determined based on a p value of less than 0.05.

Western Blot {#sec4.6}
------------

RGCs were collected and sonicated in a 2% SDS solution. Protein concentration was determined using a BCA assay (Thermo Scientific) and samples were normalized so that equal amounts of protein were loaded into each well. Lysates were mixed with 4× sample buffer plus DTT and loaded onto 4%--15% gradient gels. Gels were transferred to nitrocellulose using the Trans-Blot Turbo system (Bio-Rad), blocked with 5% milk in Tris-buffered saline (TBS) plus 0.1% Tween 20, and blotted with primary antibodies ([Table S1](#mmc1){ref-type="supplementary-material"}) overnight at 4°C. After a wash with 5% milk in TBS plus 0.1% Tween 20, secondary antibody was applied for 1 hr using donkey anti-mouse 790 or donkey anti-rabbit 790 (Jackson ImmunoResearch). Blots were washed with TBS and imaged using the LI-COR Odyssey CLx imaging system (LI-COR Biosciences). For the synaptic maturation of RGCs over time, histone H3 was used as a loading control. Fluorescence intensity was calculated for each band and normalized to histone H3 at week 1. A fold change was generated by dividing each normalized value for each synaptic protein by the normalized intensity at week 1 (n = 3). For RGCs grown alone or with astrocytes, BRN3B was used as a loading control to normalize to RGC-specific protein. Normalized relative fold changes for synaptic proteins were calculated by dividing the BRN3B normalized fluorescence intensity of each of the two groups by that of the RGCs grown alone (n = 3).

Electrophysiological Recordings {#sec4.7}
-------------------------------

Whole-cell patch-clamp recordings were made at room temperature (21°C) using a HEKA EPC 10 amplifier and Patchmaster data acquisition software (HEKA). Recording pipettes with a tip resistance of 4--7 MΩ were fabricated from borosilicate capillary glass (1.2 mm outer diameter, 0.60 mm inner diameter; Sutter Instrument Co.) using a P-1,000 puller (Sutter Instrument Co.). The bathing solution contained NaCl 140 mM, MgCl~2~ 1 mM, KCl 5 mM, CaCl~2~ 2 mM, HEPES 10 mM, glucose 10 mM (pH 7.3 adjusted with NaOH). For current-clamp recordings pipettes were filled with internal solution containing KCl 140 mM, MgCl~2~ 5 mM, CaCl~2~ 2.5 mM, EGTA 5 mM, HEPES 10 mM (pH 7.3 adjusted with KOH), and for voltage-clamp recordings the internal solution contained CsF 130 mM, NaCl 10 mM, HEPES 10 mM, CsEGTA (EGTA in CsOH) 1 mM. Inward sodium currents were recorded in voltage-clamp mode with a holding potential of −80 mV. Spontaneous AP activity was recorded in current-clamp mode at 0 pA immediately after establishing whole-cell configuration. For evoked APs, the cells were allowed to stabilize in the whole-cell configuration for 2 min before initiation of either step current injections with incremental steps of 2 pA up to 40 pA (pulse duration of 500 ms) or ramp current injection with depolarization from 0 to 40 pA for 1 s (V~hold~ = −80 mV). AP threshold was estimated from the first evoked spike using ramp current injection and was calculated using the dV/dt method. AP amplitude was measured as height of the peak from threshold and AP duration was measured as width at the threshold. When necessary, a small bias current was injected to maintain a similar baseline membrane potential (near −70 mV) before depolarizing current injections. Spontaneous post-synaptic currents were measured in the voltage-clamp mode at −80 mV.
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